Literature DB >> 24388749

Regulation of the apolipoprotein gene cluster by a long noncoding RNA.

Paul Halley1, Beena M Kadakkuzha1, Mohammad Ali Faghihi1, Marco Magistri1, Zane Zeier1, Olga Khorkova2, Carlos Coito2, Jane Hsiao2, Matthew Lawrence3, Claes Wahlestedt4.   

Abstract

Apolipoprotein A1 (APOA1) is the major protein component of high-density lipoprotein (HDL) in plasma. We have identified an endogenously expressed long noncoding natural antisense transcript, APOA1-AS, which acts as a negative transcriptional regulator of APOA1 both in vitro and in vivo. Inhibition of APOA1-AS in cultured cells resulted in the increased expression of APOA1 and two neighboring genes in the APO cluster. Chromatin immunoprecipitation (ChIP) analyses of a ∼50 kb chromatin region flanking the APOA1 gene demonstrated that APOA1-AS can modulate distinct histone methylation patterns that mark active and/or inactive gene expression through the recruitment of histone-modifying enzymes. Targeting APOA1-AS with short antisense oligonucleotides also enhanced APOA1 expression in both human and monkey liver cells and induced an increase in hepatic RNA and protein expression in African green monkeys. Furthermore, the results presented here highlight the significant local modulatory effects of long noncoding antisense RNAs and demonstrate the therapeutic potential of manipulating the expression of these transcripts both in vitro and in vivo.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24388749      PMCID: PMC3924898          DOI: 10.1016/j.celrep.2013.12.015

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  45 in total

1.  RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

Authors:  P D Zamore; T Tuschl; P A Sharp; D P Bartel
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

3.  The non-coding Air RNA is required for silencing autosomal imprinted genes.

Authors:  Frank Sleutels; Ronald Zwart; Denise P Barlow
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

Review 4.  The therapeutic potential of microRNAs: disease modulators and drug targets.

Authors:  Ailbhe M McDermott; Helen M Heneghan; Nicola Miller; Michael J Kerin
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

5.  LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.

Authors:  Antonio Adamo; Borja Sesé; Stephanie Boue; Julio Castaño; Ida Paramonov; Maria J Barrero; Juan Carlos Izpisua Belmonte
Journal:  Nat Cell Biol       Date:  2011-05-22       Impact factor: 28.824

6.  Antisense transcripts in the human genome.

Authors:  Ben Lehner; Gary Williams; R Duncan Campbell; Christopher M Sanderson
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

Review 7.  Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts.

Authors:  Marco Magistri; Mohammad Ali Faghihi; Georges St Laurent; Claes Wahlestedt
Journal:  Trends Genet       Date:  2012-04-26       Impact factor: 11.639

Review 8.  Involvement of long noncoding RNAs in diseases affecting the central nervous system.

Authors:  Chiara Pastori; Claes Wahlestedt
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

9.  lincRNAs act in the circuitry controlling pluripotency and differentiation.

Authors:  Mitchell Guttman; Julie Donaghey; Bryce W Carey; Manuel Garber; Jennifer K Grenier; Glen Munson; Geneva Young; Anne Bergstrom Lucas; Robert Ach; Laurakay Bruhn; Xiaoping Yang; Ido Amit; Alexander Meissner; Aviv Regev; John L Rinn; David E Root; Eric S Lander
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

10.  Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation.

Authors:  Farzaneh Modarresi; Mohammad Ali Faghihi; Miguel A Lopez-Toledano; Roya Pedram Fatemi; Marco Magistri; Shaun P Brothers; Marcel P van der Brug; Claes Wahlestedt
Journal:  Nat Biotechnol       Date:  2012-03-25       Impact factor: 54.908

View more
  86 in total

1.  A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.

Authors:  Xiangya Ding; Xuemei Jia; Cong Wang; Jingyun Xu; Shou-Jiang Gao; Chun Lu
Journal:  Cell Death Differ       Date:  2018-12-05       Impact factor: 15.828

Review 2.  Characters, functions and clinical perspectives of long non-coding RNAs.

Authors:  Ruifang Wu; Yuwen Su; Haijing Wu; Yong Dai; Ming Zhao; Qianjin Lu
Journal:  Mol Genet Genomics       Date:  2016-02-17       Impact factor: 3.291

Review 3.  Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins.

Authors:  Abhishek K Singh; Binod Aryal; Xinbo Zhang; Yuhua Fan; Nathan L Price; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Semin Cell Dev Biol       Date:  2017-12-06       Impact factor: 7.727

Review 4.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

5.  Oligonucleotide therapies for disorders of the nervous system.

Authors:  Olga Khorkova; Claes Wahlestedt
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

Review 6.  Long noncoding RNAs in lipid metabolism.

Authors:  Coen van Solingen; Kaitlyn R Scacalossi; Kathryn J Moore
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

Review 7.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

8.  C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.

Authors:  Kun Kim; Min-Jeong Kim; Kyung-Hee Kim; Sun-A Ahn; Jong Heon Kim; Jae Youl Cho; Seung-Gu Yeo
Journal:  Exp Ther Med       Date:  2017-03-21       Impact factor: 2.447

9.  The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.

Authors:  Elizabeth S Barrie; Katherine Hartmann; Sung-Ha Lee; John T Frater; Michal Seweryn; Danxin Wang; Wolfgang Sadee
Journal:  Hum Mutat       Date:  2016-11-07       Impact factor: 4.878

Review 10.  Lipotoxicity as a trigger factor of renal disease.

Authors:  Adriana Izquierdo-Lahuerta; Cristina Martínez-García; Gema Medina-Gómez
Journal:  J Nephrol       Date:  2016-03-08       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.